Target intelligence / Profile preview

Histone H2A type 1-H (H2AC12)

Target
H2AC12
Molecular classification
Histone, Core histone, Chromatin structural protein, Nucleosome component
01

Overview

Histone H2A type 1-H (H2AC12) is a member of the H2A core histone protein family, essential for the packaging of DNA into nucleosomes and formation of chromatin in eukaryotic cells[1][3]. Like other core histones, it contributes to the organization of chromatin, regulates DNA accessibility, and impacts gene expression through nucleosome assembly. The H2A family is highly diverse, containing multiple variants that influence chromatin dynamics and DNA-related processes such as repair, transcription, and cell cycle regulation[1][3]. Some H2A family members, including canonical forms like H2A type 1-H, have also been implicated in cellular antimicrobial responses and the DNA damage response. There is no evidence that H2AC12 functions as a direct therapeutic target (receptor, enzyme, transporter, etc.), and it does not currently represent a specific drug target, predictive biomarker, or clinical safety concern[1][3]. Alterations or mutations in histone genes in general can play a role in genome instability and are associated with various diseases including cancer, but not in an isoform-specific manner.

Other names
HIST1H2AHHIST1H2AIH2AFALiidJ86C11.1H2A/SH2A-clustered histone 12Histone H2A/sH2AHH2A histone family memberhistone H2A/shistone cluster 1 H2A family member hhistone cluster 1H2ah
02

Mechanism of action

null

03

Biological functions

DNA packagingChromatin structure maintenanceRegulation of gene expressionNucleosome assemblyDNA modification/epigeneticsAntimicrobial activityDNA damage response
04

Disease associations

Cancer (dysregulation of histone modifications implicated broadly in cancer, but not specific to this isoform[1][3])Other (genome stability and chromatin defects could be involved in multiple diseases, but no direct therapeutic targeting evidence)
05

Safety considerations

Disruption to histone H2A family members broadly may lead to widespread effects on gene regulation and cell viability; essential for normal cell function[1][3]. No therapeutic drugs specifically target this isoform.

Beyond the preview

Go deeper on Histone H2A type 1-H (H2AC12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H2A type 1-H (H2AC12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call